BusPIRone Hydrochloride Tablets USP 15 mg — Class II drug recall D-0377-2023
Terminated recall by Accord Healthcare, Inc., reported 2023-03-08, distributed in PR. CGMP Deviations: recalling drug products following an FDA inspection.
| Recall number | D-0377-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Accord Healthcare, Inc., Durham, NC, United States |
| Recall initiated | 2023-02-07 |
| Classified | 2023-03-02 |
| Reported by FDA | 2023-03-08 |
| Terminated | 2024-04-22 |
| Distributed | PR |
| Countries outside the US | CA |
| Quantity | 10,992 bottles |
| Reason classes | cgmp |
| UPC / GTIN / UDI-DI | 00316729203012 |
| NDC | 16729-0200, 16729-0200-01, 16729-0200-16, 16729-0200-17, 16729-0201, 16729-0201-01, 16729-0201-16, 16729-0201-17, 16729-0202, 16729-0202-01, 16729-0202-16, 16729-0202-17, 16729-0203, 16729-0203-01, 16729-0203-12, 16729-0203-16, 16729-0203-17, 16729-0203-59, 16729-0289, 16729-0289-01, 16729-0289-12, 16729-0289-16, 16729-0289-17, 16729-0289-59 |
| Lot numbers | P2105483 |
| Expiration dates | 2024-07-31 |
Product
BusPIRone Hydrochloride Tablets USP 15 mg, Rx Only, 100-count bottle, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA, NDC 16729-203-01, UPC 3 16729 20301 2;
Reason for recall
CGMP Deviations: recalling drug products following an FDA inspection.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0377-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.